Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
GRL0617 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021 2 0
Zinc sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021 3 0
LbuCas13a N3.2 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/03/2021 1 0
5-(((4-nitrophenoxy)carbonyl)amino)-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021 1 0